SAVIENT SHAREHOLDER CLASS ACTION SUIT DISMISSED

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT), a specialty pharmaceutical company dedicated to developing, manufacturing and marketing novel therapeutic products that address unmet medical needs, announced today that the United States District Court for the District of New Jersey dismissed, without prejudice, the Consolidated Amended Class Action Complaint filed on December 20, 2002 against the Company and three of its officers.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1034163XSL_NEWSML_TO_NEWSML_WEB.xml)